Imaging brain neuronal activity using functionalized magnetonanoparticles and MRI.

Area of Science:

• Neuroimaging
• Biomedical Engineering
• Nanotechnology

Background:

• Current methods for detecting functional brain activity often involve radioactive tracers or lack precise localization.
• There is a need for non-invasive imaging techniques that can accurately map brain function and dysfunction.

Purpose of the Study:

• To investigate the utility of non-radioactive 2-deoxy glucose (2DG)-labeled magnetonanoparticles (MNP) combined with magnetic resonance imaging (MRI) for detecting functional brain activity.
• To assess the ability of 2DG-MNP to cross the blood-brain barrier and localize areas of increased metabolic activity in animal models.

Main Methods:

• Covalently attaching non-radioactive 2DG to iron oxide and dextran-based magnetonanoparticles (MNP).
• Intravenous injection of 2DG-MNP into rodents during rest, stimulation, and in epilepsy models.
• Utilizing MRI to detect negative contrast enhancement (NCE) caused by 2DG-MNP and comparing results with autoradiography and electrophysiology.

Main Results:

• Histology confirmed MNP presence in brain tissue after intravenous injection.
• MRI successfully visualized 2DG-MNP intraparenchymal uptake, with NCE locations correlating with established 2DG autoradiography data.
• The technique accurately localized epileptogenicity in animal models, confirmed by electroencephalography (EEG).

Conclusions:

• Non-radioactive 2DG-MNP can effectively cross the blood-brain barrier and localize areas of increased cerebral activity.
• The MNP-MRI approach holds potential for imaging localized brain functions, both normal and abnormal, using various bioactive ligands.
• Further research is needed to validate this technique for human clinical applications.